
    
      This trial is a long-term, open label, safety and efficacy study of an experimental
      medication in adults with Generalized Anxiety Disorder (GAD). To enroll in this study,
      investigators and patients must have first participated in Jazz Pharmaceuticals, Inc.
      Protocol 04-001-01. The study is designed for four stages that should last a total of 37
      weeks.
    
  